Skip to main content
. 2018;19(8):2223–2227. doi: 10.22034/APJCP.2018.19.8.2223

Table 5.

Correlation of Paclitaxel Administration and Chemotherapy-Induced Peripheral Neuropathy

Paclitaxel No CIPN CIPN of any grade P-value
Frequency (weeks) 1 8 (57.1%) 15 (46.2%) 0.832
3 6 (42.9%) 24 (53.8%)
Cumulative dose Median (IQR) 320 (240 – 525) 480 (240 – 1050) 0.074
Range 160 – 1400 240 – 1400
Total no of cycles Median (IQR) 3 (3 – 3) 4 (3 – 6) 0.005
Range 2 – 8 3 – 8